PROCEPT BioRobotics (PRCT) Other Accumulated Expenses (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Other Accumulated Expenses data on file, last reported at $10.2 million in Q1 2026.

• On a quarterly basis, Other Accumulated Expenses rose 20.88% year-over-year to $10.2 million in Q1 2026; TTM through Mar 2026 was $10.2 million, a 20.88% increase from a year earlier, with the FY2025 full-year figure at $10.1 million, up 24.53% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $10.2 million, up from $10.1 million in the prior quarter.
• Over the last five years, Other Accumulated Expenses for PRCT reached as high as $10.2 million in Q1 2026 and fell as low as $4.0 million in Q1 2022.
• Historically, Other Accumulated Expenses has averaged $7.7 million across 5 years, with a median of $7.8 million in 2023.
• Across the five-year window, Other Accumulated Expenses surged 109.21% in 2022 and fell 15.4% in 2023, its largest moves.
• Year by year, Other Accumulated Expenses stood at $7.5 million in 2022, then decreased by 15.4% to $6.3 million in 2023, then increased by 28.03% to $8.1 million in 2024, then rose by 24.53% to $10.1 million in 2025, then increased by 1.75% to $10.2 million in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $10.2 million in Q1 2026, $10.1 million in Q4 2025, and $8.2 million in Q3 2025.